Drug ID: | NPD2092 |
Drug Name: | Orilotimod Potassium |
Molecular Formula: | C16H19N3O5.K |
Canonical SMILES: | OC(=O)[C@@H](Cc1c[nH]c2c1cccc2)N=C(CC[C@H](C(=O)O)N)[O-].[K+] |
Standard InCHI: | InChI=1S/C16H19N3O5.K/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12;/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24);/q;+1/p-1/t11-,13-;/m1./s1 |
Standard InCHIKey: | JBUWHGCMOSDECA-LOCPCMAASA-M |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7